Louis G. Lange, Director at Audentes Therapeutics, Inc. (BOLD), sold 32,641 shares at $27.85 ($924K) on 2017-09-25, disclosed to the SEC on 2017-09-26.
Open-market sale of $924k BOLD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.85 | 7,406 | $206K | 22.3% |
| 2 | $27.85 | 7,406 | $206K | 22.3% |
| 3 | $27.99 | 600 | $17K | 1.8% |
| 4 | $28.06 | 636 | $18K | 1.9% |
| 5 | $28.07 | 641 | $18K | 1.9% |
| 6 | $28.76 | 7,594 |
| $218K |
| 23.6% |
| 7 | $28.76 | 7,594 | $218K | 23.6% |
| 8 | $28.85 | 364 | $11K | 1.1% |
| 9 | $28.89 | 400 | $12K | 1.3% |
| Total | $28.31 avg | 32,641 | $924K | 100% |
| Filing → |
| NAMS | BUY | 2024-02-21 | $95K | — | Filing → |
| BOLD | SELL | 2019-12-27 | $656K | — | Filing → |
| BOLD | SELL | 2019-09-25 | $667K | — | Filing → |